<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a term describing the common findings of <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and marrow <z:mpath ids='MPATH_133'>hypoplasia</z:mpath> arising from a variety of <z:mp ids='MP_0002054'>disease states</z:mp>, including acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and a variety of congenital marrow failure states </plain></SENT>
<SENT sid="1" pm="."><plain>The management of children with these disorders has been confounded by difficulties of diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>The availability of molecular testing has assisted in partial resolution of this problem but has raised new issues, such as the potential of genetic predisposition and the management of asymptomatic individuals with molecular markers </plain></SENT>
<SENT sid="3" pm="."><plain>Longitudinal data from large cohort studies and disease registries are providing a rational basis for making more informed treatment decisions for children with these disorders </plain></SENT>
<SENT sid="4" pm="."><plain>In particular, the ability to subset patients more accurately has improved triage of treatments </plain></SENT>
<SENT sid="5" pm="."><plain>Approaches to hematopoietic stem cell transplantation (SCT), using both conventional and alternative donors, are changing rapidly, and the long-term sequelae of newer approaches are not entirely clear </plain></SENT>
<SENT sid="6" pm="."><plain>Improved diagnosis and longer survival have fostered an understanding of the multidisciplinary approach necessary to manage both the underlying problems and the significant sequelae of treatment in both acquired and <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disease</z:e> </plain></SENT>
</text></document>